Form 4: iRhythm Technologies Chief Commercial Officer Sells Shares Under Pre-Arranged Trading Plan

Chad Patterson, Chief Commercial Officer of iRhythm Technologies, Inc., sold 936 shares of common stock for $150 per share on June 23, 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Chad Patterson, the Chief Commercial Officer of iRhythm Technologies, Inc. (IRTC), reported a sale of company common stock.
• The transaction involved the disposition of 936 shares of common stock.
• The sale occurred on June 23, 2025, with a deemed execution date also on June 23, 2025.
• Each share was sold at a price of $150.
• Following this transaction, Mr. Patterson directly beneficially owns 48,929 shares of iRhythm Technologies common stock.
• The sale was executed under a Rule 10b5-1 trading plan, which was established by Mr. Patterson on November 25, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, it was conducted under a pre-arranged 10b5-1 plan, which is a common practice for executive liquidity management and does not necessarily signal a negative outlook on the company.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 trading plan, indicating a planned transaction rather than a reaction to new, non-public information, which enhances transparency.

Negatives

• An insider sale, even if pre-planned, reduces the direct equity stake of a key executive in the company.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale by a Chief Commercial Officer could be perceived as a minor reduction in management's direct alignment with shareholder interests, though mitigated by the 10b5-1 plan.

Key Dates

Keywords

iRhythm Technologies, IRTC, Chad Patterson, Chief Commercial Officer, SEC Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Equity Transaction